Work

scAAVIL-1ra dosing trial in a large animal model and validation of long-term expression with repeat administration for osteoarthritis therapy

Year: 2015

Type: article

Source: Gene Therapy

DOI: 10.1038/gt.2015.21

Authors: L R Goodrich, J C Grieger, J N Phillips, N Khan, S J Gray, C W McIlwraith, R J Samulski

Institutions: Colorado State University, University of North Carolina at Chapel Hill

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Grayson-Jockey Club Research Foundation, National Institute for Health and Care Research, Israel National Institute for Health Policy Research, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: Rational and Combinatorial Engineering of AAV Vectors, NEUTRALIZING ANTIBODY & AAV FIX GENE THERAPY, Gene Therapeutic Approaches to Cartilage Repair, Overcoming our clinical complications: AAV vector design for the treatment of DMD, G5337339909, UNC PREP in the Biomedical Sciences, G851873780

OpenAlex ID: W2016170000

FWCI: 3.017

Cites: 58

Cited by: 47

Related to: 10